Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab

BACKGROUND: Pure red cell aplasia and moderate aplastic anemia are marrow failure states with an immune pathogenesis. Previously, we described short-term improvements in blood counts in two pilot studies treating moderate aplastic anemia (mAA) and pure red cell aplasia (PRCA) patients with daclizuma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sloand, Elaine M., Olnes, Matthew J., Weinstein, Barbara, Wu, Colin, Maciejewski, Jaroslaw, Scheinberg, Phillip, Young, Neal S.
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2010
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2833067/
https://ncbi.nlm.nih.gov/pubmed/20207845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.013557
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados